| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Chief Executive Officer
1 company
Kenneth Michael Reali last filed a Form 4 in March 2022, as Chief Executive Officer at BVS. Kenneth Michael Reali's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 30,085 shares of BVS. Net of sales, the BVS filings show accumulation of 1,364 shares.
Kenneth Michael Reali has 3 Form 4 filings on record from February 2021 to March 2022, all as Chief Executive Officer at Bioventus (BVS), 2021–2022.
The 6 reported transactions were 2 option or other derivative awards, 2 open-market purchases, 1 option exercise and 1 open-market sale.
Counted by filing, the open-market trades come to 2 purchases worth about $149K and 1 sale worth about $14K.
The largest open-market purchase was 9,375 shares of BVS at an average $13.00 on February 11, 2021, about $122K.
The only open-market sale was 9,811 shares of BVS at an average $1.39 on March 15, 2023, about $14K. Twelve months later BVS was up 218%.
Shares as reported in the last Form 4 for each company; the most recent is from March 2022. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 15, 2023 | BVS Bioventus Inc. | Chief Executive Officer | Sale+OE | 9,811 | $1.39 | $13,624.54 | -24.6% | +89.6% | +218.4% | |
| Sep 9, 2021 | BVS Bioventus Inc. | Chief Executive Officer | Buy | 1,800 | $14.81 | $26,658.00 | +19.2% | -7.2% | -45.7% | |
| Feb 11, 2021 | BVS Bioventus Inc. | Chief Executive Officer | Buy | 9,375 | $13.00 | $121,875.00 | New | - | - |